AR and breast cancer: Kevin Kensler from the Dana-Farber Cancer Institute in Boston, Massachusetts, USA, and colleagues quantified expression of the androgen receptor (AR) in biopsy tissue taken from 354 women with benign breast disease, 78 of whom were later diagnosed with breast cancer.